1.
Stieglitz E, Taylor-Weiner AN, Chang TY, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015;47(11):1326-1333. doi:10.1038/ng.3400.
1.
Boettger LM, Handsaker RE, Zody MC, McCarroll SA. Structural haplotypes and recent evolution of the human 17q21.31 region. Nat Genet. 2012;44(8):881-5. doi:10.1038/ng.2334.
1.
Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506(7487):185-90. doi:10.1038/nature12975.
1.
Cai X, Evrony GD, Lehmann HS, et al. Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep. 2014;8(5):1280-9. doi:10.1016/j.celrep.2014.07.043.
1.
Franke L, Bannoudi H el, Jansen DTSL, et al. Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes. Eur J Hum Genet. 2016;24(2):263-70. doi:10.1038/ejhg.2015.95.
1.
Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73. doi:10.1038/nature12113.
1.
Garraway LA. Concordance and discordance in tumor genomic profiling. J Clin Oncol. 2012;30(24):2937-9. doi:10.1200/JCO.2011.41.3138.
1.
Rees E, Kirov G, Sanders A, et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry. 2014;19(1):37-40. doi:10.1038/mp.2013.156.
1.
Levinson DF, Mostafavi S, Milaneschi Y, et al. Genetic studies of major depressive disorder: why are there no genome-wide association study findings and what can we do about it?. Biol Psychiatry. 2014;76(7):510-2. doi:10.1016/j.biopsych.2014.07.029.
1.
Black JC, Atabakhsh E, Kim J, et al. Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. Genes Dev. 2015;29(10):1018-31. doi:10.1101/gad.259796.115.